kt
treatment
choic
esrd
result
increas
durat
qualiti
life
patient
worldwid
number
kt
increas
year
usa
among
patient
treat
esrd
receiv
renal
allograft
compar
franc
preval
esrd
patient
treat
kt
patient
howev
success
transplant
requir
administr
immunosuppress
therapi
prevent
allograft
reject
inextric
link
infect
antiinfect
regimen
make
immunosuppress
therapi
safer
complet
prevent
occurr
increas
sever
infecti
diseas
thu
infect
remain
import
concern
constitut
secondlead
caus
mortal
among
ktr
behind
cardiovascular
complic
virus
import
caus
infect
repres
major
sourc
morbid
mortal
ktr
may
acquir
viral
infect
exogen
rout
includ
commun
exposur
donor
organ
blood
product
endogen
reactiv
latent
virus
virusassoci
diseas
may
manifest
direct
ill
indirect
effect
mediat
immunomodul
virus
fulli
display
potenti
danger
ktr
immunecompet
individu
ktr
typic
viral
infect
caus
herpesvirida
hepat
virus
hiv
papillomavirida
howev
sever
emerg
viral
diseas
recent
highlight
popul
word
emerg
appli
viral
diseas
variou
mean
emerg
viral
diseas
diseas
newli
appear
popul
recogn
earlier
whose
incid
geograph
rang
increas
reemerg
viral
diseas
diseas
reappear
differ
geograph
area
emerg
correspond
appear
new
virus
reli
migrat
peopl
reservoir
vector
new
environment
condit
new
behavior
new
medic
practic
altern
emerg
reflect
improv
awar
clinician
diseas
lead
increas
test
diagnosi
final
emerg
reli
implement
new
diagnost
tool
reveal
level
incid
preval
previous
underestim
recent
decad
favor
emerg
viral
agent
viral
diseas
notabl
urban
global
shown
dramat
expans
concurr
new
technolog
medic
practic
implement
use
increas
case
organ
transplant
tool
scientif
medic
inform
grown
significantli
moreov
number
perform
viral
detect
method
evolv
dramat
last
decad
particularli
molecular
method
increasingli
implement
clinic
virolog
consider
impact
field
allow
rapid
detect
virus
includ
cultiv
laboratori
purpos
review
provid
updat
emerg
viral
diseas
newli
discov
virus
ktr
first
perform
search
ncbi
pubm
databas
use
keyword
viru
viral
infect
kidney
transplant
limit
search
human
last
year
obtain
refer
check
refer
identifi
name
viru
famili
virus
titl
abstract
refer
confirm
virus
occur
public
field
kt
cmv
refer
total
number
refer
hcv
refer
ebv
refer
hbv
refer
hiv
refer
human
papillomaviru
refer
figur
focus
virus
yearli
evolut
number
articl
quot
paper
avail
last
year
figur
viru
number
citat
show
greatest
increas
period
bkv
follow
gb
viru
wnv
jcv
influenza
viru
hev
figur
final
possibl
relat
emerg
diseas
ktr
newli
discov
virus
search
ncbi
pubm
databas
viru
human
polyomavirus
bk
jc
recogn
caus
agent
polyomavirusassoci
nephropathi
bk
major
etiolog
agent
bkv
first
isol
ktr
present
ureter
stenosi
viru
name
bkv
initi
patient
tabl
bkv
discov
well
clinic
consequ
infect
could
appreci
ktr
first
case
bkv
interstiti
nephriti
diagnos
renal
allograft
biopsi
patient
acut
renal
failur
infect
bkv
jcv
occur
earli
life
benign
blood
donor
igg
seropreval
bkv
jcv
respect
wherea
viruria
rate
neither
bkv
jcv
detect
plasma
distribut
latent
virus
differ
tissu
thought
occur
primari
viremia
bestknown
site
bkv
jcv
latenc
urogenit
tract
bk
viral
sequenc
detect
bladder
prostat
tissu
kidney
procur
asymptomat
individu
kt
incid
viruria
increas
jcv
bkv
infect
one
polyomaviru
neg
associ
reactiv
bkv
reactiv
like
occur
cell
donor
kidney
year
bkvan
emerg
misdiagnosi
acut
cellular
reject
instead
viral
nephriti
like
result
unnecessari
antireject
treatment
could
inflat
rate
allograft
loss
record
earlier
studi
proactiv
approach
accur
earli
diagnosi
decreas
incid
bkvanrel
graft
loss
less
reactiv
bkv
uret
manifest
ureter
stenosi
bladder
manifest
hemorrhag
cystiti
renal
cell
carcinoma
graft
carcinoma
bladder
increasingli
consid
complic
bkv
oncogen
properti
routin
screen
present
import
tool
use
identifi
patient
increas
risk
bkvan
detect
viremia
requir
ktr
high
level
urinari
bkv
replic
decoy
cell
bkv
load
copiesml
progress
bk
viremia
bkvan
screen
especi
recommend
first
year
kt
whenev
unexplain
serum
creatinin
rise
occur
jcv
isol
brain
patient
suffer
hodgkin
diseas
pml
viru
name
jcv
initi
patient
tabl
jcv
caus
agent
pml
immunodefici
patient
establish
pml
result
primari
infect
reactiv
latent
viru
normal
brain
may
site
jcv
latenc
reactiv
viru
lead
lytic
infect
glial
cell
onset
pml
case
failur
immunosurveil
howev
pml
occur
rare
ktr
retrospect
studi
nine
case
pml
identifi
among
adult
ktr
correspond
incid
personyear
caus
agent
ks
describ
moritz
kaposi
kaposi
describ
sporad
classic
subtyp
iatrogen
subtyp
subsequ
describ
immunocompromis
patient
particularli
ktr
discov
use
rda
healthi
skin
ks
tumor
obtain
aid
patient
tabl
primari
infect
immunecompet
individu
associ
mild
nonspecif
symptom
fatigu
diarrhea
rash
lymphadenopathi
follow
primari
infect
establish
latenc
mainli
b
lymphocyt
spindl
cell
geograph
restrict
viru
incid
vari
low
incid
north
america
high
incid
africa
amazon
basin
contrarili
pathogen
potenti
ktr
clear
prospect
studi
ks
due
reactiv
case
due
primari
infect
case
seroneg
ktr
receiv
kidney
seroposit
donor
seroposit
ktr
independ
risk
factor
ks
age
black
skin
screen
donor
recipi
recommend
assess
risk
geograph
region
high
rate
infect
monitor
viremia
kt
determin
risk
diseas
seroposit
recipi
receiv
kidney
seroposit
donor
mean
time
kt
ks
onset
month
rang
week
year
skin
lesion
seen
case
ks
lesion
dark
blue
purplish
color
white
skin
figur
often
appear
pigment
black
skin
initi
macular
subsequ
infiltr
sometim
nodular
cutan
lesion
occur
extrem
viscer
involv
observ
case
ks
oral
lesion
consist
predominantli
purpl
stain
palat
associ
viscer
involv
gastrointestin
tract
typic
detect
red
spot
endoscop
examin
asymptomat
patient
viscer
site
ks
lymph
node
lung
figur
regardless
local
diagnosi
ks
base
histolog
featur
typic
lesion
exhibit
network
spindleshap
cell
larg
vascular
space
surround
endotheli
cell
layer
immunochemistri
use
mab
direct
antigen
use
patholog
diagnosi
pcr
detect
viral
replic
diseas
includ
bodi
cavitybas
pel
mcd
ptld
occur
rare
ktr
case
report
literatur
summar
tabl
besid
primari
infect
result
nonmalign
diseas
potenti
lethal
acut
syndrom
character
fever
hemophagocyt
syndrom
bone
marrow
failur
risk
factor
less
common
clinic
manifest
infect
defin
hev
discov
outbreak
unexplain
hepat
occur
soviet
soldier
afghanistan
tabl
balayan
present
hepat
ingest
pool
stool
extract
patient
detect
viru
stool
em
hev
lead
caus
acut
hepat
adult
develop
countri
hyperendem
genotyp
princip
water
born
develop
countri
hepat
e
first
consid
import
hev
hyperendem
geograph
area
current
emerg
autochthon
ie
local
acquir
diseas
porcin
zoonosi
caus
hev
genotyp
hepat
e
typic
caus
acut
selflimit
infect
immunecompet
individu
howev
fulmin
hepat
high
mortal
describ
reach
case
involv
pregnanc
develop
countri
case
involv
underli
liver
diseas
first
case
hev
infect
ktr
report
india
patient
die
sever
acut
pancreat
attribut
hev
infect
elev
serum
alanin
aminotransferas
bilirubin
level
posit
antihev
igm
surprisingli
normal
serum
amylas
level
european
autochthon
acut
hev
infect
ktr
first
describ
toulous
franc
incid
hev
infect
estim
personyear
kt
southwestern
franc
independ
predict
factor
hev
infect
sotr
consumpt
game
meat
ktr
acut
hepat
e
mostli
asymptomat
liver
enzym
level
lower
histolog
lesion
less
sever
seen
immunecompet
individu
variou
extrahepat
manifest
describ
ktr
associ
hev
infect
includ
transient
cryoglobulinemia
glomerulonephr
neurolog
symptom
involv
peripher
cn
hev
infect
emerg
clinic
concern
among
ktr
europ
chronic
infect
associ
autochthon
genotyp
hev
describ
chronic
hepat
e
defin
hepat
persist
infect
document
pcr
last
month
incid
chronic
evolut
hev
infect
estim
ktr
clinic
studi
suggest
occurr
persist
chronic
hepat
e
relat
immunolog
statu
patient
inde
form
hepat
e
describ
sever
immunocompromis
patient
especi
sotr
hivinfect
patient
individu
hematolog
diseas
pool
sotr
occurr
chronic
hepat
e
relat
dose
immunosuppress
acut
form
chronic
hepat
e
often
subclin
ktr
mild
liver
abnorm
figur
twentyseven
chronic
hepat
e
case
report
western
europ
sinc
evolut
cirrhosi
may
occur
rapidli
hev
infect
three
four
report
case
hevrel
cirrhosi
die
decompens
cirrhosi
discov
systemat
screen
hepat
b
nine
healthi
blood
donor
patient
acut
hepat
patient
receiv
renal
allograft
week
earlier
without
specif
ill
associ
time
tabl
primari
infect
often
occur
earli
life
immunecompet
individu
infect
gener
asymptomat
may
manifest
children
mild
rash
call
erythema
infectiosum
fifth
diseas
adult
polyarthr
first
descript
hypoplast
crisi
infect
date
patient
sicklecel
anemia
anemia
result
viral
replic
erythroid
progenitor
lead
apoptosi
typic
refractori
sever
rare
leukopenia
thrombocytopenia
present
renal
graft
dysfunct
hepat
exist
ktr
respect
collaps
glomerulopathi
thrombot
microangiopathi
report
renal
allograft
manifest
seldom
report
includ
pneumon
enceph
unresolv
human
rhinoviru
c
molecular
human
rhinoviru
screen
npa
prospect
collect
hospit
children
acut
respiratori
tract
infect
neg
common
respiratori
virus
coinfect
human
bocaviru
case
myocard
hemophagocyt
syndrom
bone
marrow
examin
typic
reveal
red
cell
aplasia
figur
diagnosi
infect
base
serolog
test
bloodbon
marrow
pcr
bone
marrow
examin
persist
viral
replic
blood
demonstr
ktr
sever
month
correct
hematolog
abnorm
chronic
infect
manifest
chronic
anemia
relaps
anemia
relaps
anemia
frequent
primari
infect
recurr
infect
occur
ktr
new
strain
influenza
first
recogn
result
worldwid
pandem
tabl
pandem
character
reassort
viru
gene
swine
avian
human
influenza
virus
sever
diseas
note
children
pregnant
women
peopl
comorbid
disord
includ
chronic
lung
heart
diseas
diabet
obes
sotr
pandem
result
spectrum
ill
rang
mild
selflimit
sever
diseas
largest
studi
report
data
sotr
north
america
major
ktr
common
present
symptom
cough
fever
myalgia
rhinorrhoea
sore
throat
headach
lung
imag
show
pneumonia
patient
diagnos
pcr
nasopharyng
swab
figur
incid
hospit
rate
admiss
intens
care
unit
patient
need
mechan
ventil
two
adult
one
child
receiv
extracorpor
membran
oxygen
type
transplant
patient
specifi
seem
affect
outcom
ten
adult
die
overal
mortal
rate
differ
studi
show
morbid
mortal
observ
ktr
nonimmunocompromis
patient
infect
pandem
similar
wnv
exampl
previous
known
pathogen
whose
emerg
relat
epidemiolog
factor
favor
spread
appear
wnv
new
york
panzoot
follow
drawn
attent
viru
isol
first
time
woman
suffer
fever
provinc
west
nile
uganda
tabl
wherea
wnv
fever
may
real
emerg
diseas
america
peak
activ
affect
person
includ
case
neuroinvas
diseas
death
old
world
less
human
death
record
past
decad
bird
primari
reservoir
wnv
figur
mosquito
vector
acquir
infect
feed
virem
bird
transmit
human
bite
immunecompet
individu
infect
asymptomat
wherea
selflimit
febril
ill
may
accompani
maculopapular
rash
estim
rate
neurolog
involv
less
ktr
may
acquir
wnv
three
primari
mechan
infect
organ
donor
infect
blood
product
communityacquir
exposur
date
wnv
infect
kt
blood
product
transfus
report
six
ktr
tabl
major
report
wnv
infect
ktr
describ
infect
acquir
mosquito
exposur
occur
month
year
posttranspl
incub
period
seem
longer
among
sotr
among
gener
popul
studi
conduct
sotr
epidem
wnv
canada
found
seropreval
low
risk
neurolog
diseas
much
higher
gener
popul
sotr
time
greater
risk
symptomat
infect
normal
host
new
virus
discov
two
differ
set
wellcharacter
human
diseas
exampl
outbreak
tabl
preval
wu
ki
polyomavirus
establish
plasma
urin
upper
respiratori
tract
specimen
ktr
patient
posit
respiratori
specimen
acut
upper
respiratori
tract
infect
none
sampl
test
acut
respiratori
viru
preval
wu
ki
polyomavirus
determin
immunocomprom
patient
ki
polyomaviru
detect
patient
rtpcr
one
ktr
present
acut
upper
respiratori
tract
infect
coinfect
human
rhinoviru
sampl
posit
virus
npa
due
systemat
screen
sampl
tabl
latter
case
virus
found
human
sampl
collect
authent
infecti
syndrom
laboratori
without
clinic
data
clinic
signific
newli
discov
virus
without
accompani
clinic
data
often
unknown
contrast
new
virus
discov
human
outbreak
clearli
pathogen
zoonot
tabl
among
virus
discov
viru
clearli
caus
emerg
diseas
ktr
new
respiratori
virus
studi
ktr
figur
summar
studi
tabl
howev
commun
exposur
ktr
respiratori
virus
import
consequ
respiratori
viral
infect
includ
higher
rate
viral
pneumonia
ktr
immunecompet
individu
increas
risk
superinfect
bacteri
fungal
pathogen
nevertheless
identif
virus
respiratori
infect
ktr
difficult
prospect
studi
respiratori
viral
infect
detect
respiratori
viru
posit
case
larg
specif
antivir
drug
reduc
immunosuppress
therapi
iv
ig
infus
given
clinic
respons
reticulocytosi
correct
anemia
erythrocyt
transfus
could
requir
specif
antivir
drug
reduc
discontinu
immunosuppress
therapi
treatment
mainli
support
prospect
control
studi
ktr
comprehens
viral
test
need
establish
epidemiolog
determin
whether
newli
discov
respiratori
virus
caus
respiratori
diseas
popul
final
sever
report
publish
gb
viru
c
ttv
ktr
peak
respect
decreas
despit
fact
gb
viru
c
ttv
first
found
serum
sampl
patient
unexplain
hepat
paper
dismiss
signific
role
virus
etiolog
agent
diseas
immunecompet
individu
ktr
supplementari
tabl
treatment
except
flu
hepat
e
avail
antivir
intervent
reduc
immunosuppress
therapi
support
treatment
main
recommend
treatment
emerg
viral
diseas
present
vaccin
limit
efficaci
seroconvers
rate
around
safe
ktr
influenza
pandem
tabl
review
summar
current
knowledg
virus
shown
greatest
increas
last
two
decad
field
kt
accord
number
citat
viral
diseas
discuss
result
endogen
reactiv
commun
exposur
often
first
describ
immunosuppress
popul
clinic
express
becom
appar
sever
year
discoveri
viru
apart
virus
discov
last
two
decad
infrequ
involv
clinic
diseas
ktr
nonetheless
favor
circumst
pathogen
newli
discov
viru
fulli
express
long
discoveri
virolog
remain
fastmov
field
implement
new
technolog
technolog
help
detect
new
old
pathogen
undiagnos
infect
also
influenti
conduct
technologybas
research
virus
suspect
abund
inhabit
biospher
number
approxim
human
bodi
metagenom
allow
us
character
virom
clinic
sampl
reveal
presenc
expect
unexpect
virus
larg
number
viral
coinfect
increas
use
tool
special
popul
ktr
particularli
concern
infecti
diseas
might
lead
breakthrough
knowledg
biolog
clinic
impact
virus
